Skip to main content
SpringerLink
Log in

Botulinum Toxin Treatment in Veterinary Medicine: Clinical Implications

  • Chapter
  • First Online:
Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine

Abstract

Botulinum toxin (BoNT) products are not licensed for veterinary use, but there are studies investigating its therapeutic potential in veterinary medicine, mainly in dogs and horses. Some efficacy has been reported for BoNT in the treatment of osteoarthritic and perioperative pain in dogs and in the treatment of lameness in horses in small controlled clinical trials. In addition, few case series have described the use of BoNT in the treatment of lower esophageal sphincter achalasia-like syndrome, urinary incontinence, and prostatic hypertrophy in dogs and in stringhalt in horses. Further thoroughly planned controlled clinical trials with objective outcome measures are needed to reveal the true relevance of BoNT in veterinary medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lindström M, Nevas M, Kurki J, Sauna-Aho R, Latvala-Kiesilä A, Pölönen I, et al. Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland. J Clin Microbiol. 2004;42(10):4718.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Johnson AL, McAdams SC, Whitlock RH. Type A botulism in horses in the United States: a review of the past ten years (1998–2008). J Vet Diagn Investig. 2010;22(2):165–73.

    Article  Google Scholar 

  3. Payne JH, Hogg RA, Otter A, et al. Emergence of suspected type D botulism in ruminants in England and Wales (2001 to 2009), associated with exposure to broiler litter. Vet Rec. 2011;168(24):640.

    Article  CAS  PubMed  Google Scholar 

  4. Johnston SA. Osteoarthritis: joint anatomy, physiology, and pathobiology. Vet Clin North Am Small Anim Pract. 1997;27(4):699–723.

    Article  CAS  PubMed  Google Scholar 

  5. Anderson KL, O’Neill DG, Brodbelt DC, Church DB, Meeson RL, Sargan D, et al. Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Sci Rep. 2018;8(1):5641–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Bonnett BN, Egenvall A, Hedhammar A, Olson P. Mortality in over 350,000 insured Swedish dogs from 1995–2000: I. Breed-, gender-, age- and cause-specific rates. Acta Vet Scand. 2005;46(3):105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Moore GE, Burkman KD, Carter MN, Peterson MR. Causes of death or reasons for euthanasia in military working dogs: 927 cases (1993–1996). J Am Vet Med Assoc. 2001;219(2):209–14.

    Article  CAS  PubMed  Google Scholar 

  8. Hadley HS, Wheeler JL, Petersen SW. Effects of intra-articular botulinum toxin type A (Botox®) in dogs with chronic osteoarthritis. Vet Comp Orthop Traumatol. 2010;9:254–8.

    Google Scholar 

  9. Voss K, Imhof J, Kaestner S, Montavon PM. Force plate gait analysis at the walk and trot in dogs with low-grade hindlimb lameness. Vet Comp Orthop Traumatol. 2007;20(4):299–304.

    Article  CAS  PubMed  Google Scholar 

  10. Volstad N, Nemke B, Muir P. Variance associated with the use of relative velocity for force platform gait analysis in a heterogeneous population of clinically normal dogs. Vet J. 2016;207:80–4.

    Article  PubMed  Google Scholar 

  11. Heikkilä HM, Hielm-Björkman AK, Morelius M, Larsen S, Honkavaara J, Innes JF, et al. Intra-articular botulinum toxin A for the treatment of osteoarthritic joint pain in dogs: a randomized, double-blinded, placebo-controlled clinical trial. Vet J. 2014;200(1):162–9.

    Article  PubMed  CAS  Google Scholar 

  12. Hielm-Björkman AK, Kuusela E, Liman A, Markkola A, Saarto E, Huttunen P, et al. Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J Am Vet Med Assoc. 2003;222(11):1552–8.

    Article  PubMed  Google Scholar 

  13. Nicácio GM, Luna SPL, Cavaleti P, Cassu RN. Intra-articular botulinum toxin A (BoNT/A) for pain management in dogs with osteoarthritis secondary to hip dysplasia: A randomized controlled clinical trial. J Vet Med Sci. 2019;81(3):411–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Brown DC, Boston RC, Coyne JC, Farrar JT. Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res. 2007;68(6):631–7.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sampaio C, Ferreira JJ, Simões F, Rosas MJ, Magalhães M, Correia AP, et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1. Mov Disord. 1997;12(6):1013–8.

    Article  CAS  PubMed  Google Scholar 

  16. Odergren T, Hjaltason H, Kaakkola S, Solders G, Hanko J, Fehling C, et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry. 1998;64(1):6–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Conzemius MG, Evans RB. Caregiver placebo effect for dogs with lameness from osteoarthritis. J Am Vet Med Assoc. 2012;241(10):1314–9.

    Article  PubMed  Google Scholar 

  18. Safarpour Y, Jabbari B. Botulinum toxin treatment of pain syndromes -an evidence based review. Toxicon. 2018;147:120–8.

    Article  CAS  PubMed  Google Scholar 

  19. Heikkilä HM, Jokinen TS, Syrjä P, Junnila J, Hielm-Björkman A, Laitinen-Vapaavuori O. Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: a placebo-controlled, blinded, randomized trial. Premkumar LS, editor. PloS One. 2018;13(1):e0191043.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Vilhegas S, Cassu RN, Barbero RC, Crociolli GC, Rocha TLA, Gomes DR. Botulinum toxin type A as an adjunct in postoperative pain management in dogs undergoing radical mastectomy. Vet Rec. 2015;177(15):391.

    Article  CAS  PubMed  Google Scholar 

  21. Murrell JC, Psatha EP, Scott EM, Reid J, Hellebrekers LJ. Application of a modified form of the Glasgow pain scale in a veterinary teaching centre in the Netherlands. Vet Rec. 2008;162(13):403–8.

    Article  CAS  PubMed  Google Scholar 

  22. Layeeque R, Hochberg J, Siegel E, Kunkel K, Kepple J, Henry-Tillman RS, et al. Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann Surg. 2004;240(4):608–13; discussion 613–4.

    PubMed  PubMed Central  Google Scholar 

  23. Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci. 2008;28(14):3689–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bach-Rojecky L, Lacković Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav. 2009;94(2):234–8.

    Article  CAS  PubMed  Google Scholar 

  25. Grobman ME, Hutcheson KD, Lever TE, Mann FA, Reinero CR. Mechanical dilation, botulinum toxin A injection, and surgical myotomy with fundoplication for treatment of lower esophageal sphincter achalasia-like syndrome in dogs. J Vet Intern Med. 2019;33(3):1423–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rogatko CP, Glass EN, Kent M, Hammond JJ, de Lahunta A. Use of botulinum toxin type A for the treatment of radiation therapy-induced myokymia and neuromyotonia in a dog. J Am Vet Med Assoc. 2016;248(5):532–7.

    Article  CAS  PubMed  Google Scholar 

  27. Schubert T, Clemmons R, Miles S, Draper W. The use of botulinum toxin for the treatment of generalized myoclonus in a dog. J Am Anim Hosp Assoc. 2013;49(2):122–7.

    Article  PubMed  Google Scholar 

  28. Rinaldi ML, Fransson BA, Barry SL. Botulinum toxin A as a treatment for delayed gastric emptying in a dog. Can Vet J. 2014;55(7):673–7.

    PubMed  PubMed Central  Google Scholar 

  29. Kessler KR, Benecke R. Botulinum toxin: from poison to remedy. Neurotoxicology. 1997;18(3):761–70.

    CAS  PubMed  Google Scholar 

  30. Meyer-Lindenberg A, Wohlfarth KM, Switzer EN. The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog. Aust Vet J. 2003;81(10):612–4.

    Article  CAS  PubMed  Google Scholar 

  31. Bright SR, Girling SL, O’Neill T, Innes JF. Partial tarsal arthrodesis and botulinum toxin A injection for correction of tarsal arthrogryposis in a cat. J Small Anim Pract. 2007;48(1):39–42.

    Article  CAS  PubMed  Google Scholar 

  32. Arruda RM, Takano CC, Girão MJBC, Haddad JM, Aleixo GF, Castro RA. Treatment of non-neurogenic overactive bladder with OnabotulinumtoxinA: systematic review and meta-analysis of prospective, randomized, placebo-controlled clinical trials. RBGO Gynecol Obstet. 2018;40(4):225–31.

    Google Scholar 

  33. Cooley LF, Kielb S. A review of botulinum toxin A for the treatment of neurogenic bladder. PM&R. 2019;11(2):192–200.

    Article  Google Scholar 

  34. Coelho A, Dinis P, Pinto R, Gorgal T, Silva C, Silva A, et al. Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder. Eur Urol. 2010;57(5):884–90.

    Article  CAS  PubMed  Google Scholar 

  35. Lew S, Majewski M, Radziszewski P, Kuleta Z. Therapeutic efficacy of botulinum toxin in the treatment of urinary incontinence in female dogs. Acta Vet Hung. 2010;58(2):157–65.

    Article  CAS  PubMed  Google Scholar 

  36. Mostachio GQ, Apparício M, Motheo TF, Alves AE, Vicente WRR. Intra-prostatic injection of botulinum toxin type A in treatment of dogs with spontaneous benign prostatic hyperplasia. Anim Reprod Sci. 2012;133(3–4):224–8.

    Article  CAS  PubMed  Google Scholar 

  37. Johnston SD, Kamolpatana K, Root-Kustritz MV, Johnston GR. Prostatic disorders in the dog. Anim Reprod Sci. 2000;60–61:405–15.

    Article  PubMed  Google Scholar 

  38. Shim SR, Cho YJ, Shin I-S, Kim JH. Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis. Int Urol Nephrol. 2016;48(1):19–30.

    Article  CAS  PubMed  Google Scholar 

  39. Hansen KS, Weisse C, Berent AC, Dunn M, Caceres AV, Todd KL, et al. Use of a self-expanding metallic stent to palliate esophageal neoplastic obstruction in a dog. J Am Vet Med Assoc. 2012;240(10):1202–7.

    Article  PubMed  Google Scholar 

  40. Bittencourt MKW, de Vasconcellos JPC, Bittencourt MD, Malagó R, Bacellar M. J Ocul Pharmacol Ther. 2013;29(4):431–6.

    Article  CAS  PubMed  Google Scholar 

  41. Cohen SR, Thompson JW, Camilon FS Jr. Botulinum toxin for relief of bilateral abductor paralysis of the larynx: histologic study in an animal model. Ann Otol Rhinol Laryngol. 1989;98(3):213–6.

    Article  CAS  PubMed  Google Scholar 

  42. Lin ATL, Yang AH, Chen KK. Effects of botulinum toxin A on the contractile function of dog prostate. Eur Urol. 2007;52(2):582–9.

    Article  CAS  PubMed  Google Scholar 

  43. Tsuboi M, Furukawa Y, Kurogouchi F, Nakajima K, Hirose M, Chiba S. Botulinum neurotoxin A blocks cholinergic ganglionic neurotransmission in the dog heart. Jpn J Pharmacol. 2002;89(3):249–54.

    Article  CAS  PubMed  Google Scholar 

  44. Brodsky JA, Marks JM, Malm JA, Bower A, Ponsky JL. Sphincter of Oddi injection with botulinum toxin is as effective as endobiliary stent in resolving cystic duct leaks in a canine model. Gastrointest Endosc. 2002;56(6):849–51.

    Article  PubMed  Google Scholar 

  45. Shaari CM, Wu BL, Biller HF, Chuang SK, Sanders I. Botulinum toxin decreases salivation from canine submandibular glands. Otolaryngol Head Neck Surg. 1998;118(4):452–7.

    CAS  PubMed  Google Scholar 

  46. Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg. 1995;112(4):566–71.

    CAS  PubMed  Google Scholar 

  47. Wylie CE, Collins SN, Verheyen KLP, Newton JR. Frequency of equine laminitis: a systematic review with quality appraisal of published evidence. Vet J. 2011;189(3):248–56.

    Article  PubMed  Google Scholar 

  48. Baxter GM, Morrison S. Complications of unilateral weight bearing. Vet Clin N Am Equine Pract. 2008;24(3):621–42, ix.

    Article  Google Scholar 

  49. Patterson-Kane JC, Karikoski NP, McGowan CM. Paradigm shifts in understanding equine laminitis. Vet J. 2018;231:33–40.

    Article  CAS  PubMed  Google Scholar 

  50. Carter DW, Renfroe BJ. A novel approach to the treatment and prevention of laminitis: botulinum toxin type A for the treatment of laminitis. J Equine Vet. 2009;29(7):595–600.

    Article  Google Scholar 

  51. van Eps AW, Burns TA. Are there shared mechanisms in the pathophysiology of different clinical forms of laminitis and what are the implications for prevention and treatment? Vet Clin N Am Equine Pract. 2019;35(2):379–98.

    Article  Google Scholar 

  52. Bamford NJ. Clinical insights: treatment of laminitis. Equine Vet J. 2019;51(2):145–6.

    Article  CAS  PubMed  Google Scholar 

  53. Eastman TG, Honnas CM, American BHJOT, 1999. Deep digital flexor tenotomy as a treatment for chronic laminitis in horses: 35 cases (1988–1997). J Equine Vet Sci. 2010;30(2):111.

    Article  Google Scholar 

  54. Hardeman LC, van der Meij BR, Oosterlinck M, Veraa S, van der Kolk JH, Wijnberg ID, et al. Effect of Clostridium botulinum toxin type A injections into the deep digital flexor muscle on the range of motion of the metacarpus and carpus, and the force distribution underneath the hooves, of sound horses at the walk. Vet J. 2013;198:e152–6.

    Article  CAS  PubMed  Google Scholar 

  55. Wijnberg ID, Hardeman LC, van der Meij BR, Veraa S, Back W, van der Kolk JH. The effect of Clostridium botulinum toxin type A injections on motor unit activity of the deep digital flexor muscle in healthy sound Royal Dutch sport horses. Vet J. 2013;198:e147–51.

    Article  PubMed  Google Scholar 

  56. Hardeman LC, van der Meij BR, Back W, van der Kolk JH, Wijnberg ID. The use of electromyography interference pattern analysis to determine muscle force of the deep digital flexor muscle in healthy and laminitic horses. Vet Q. 2015;36(1):10–5.

    Article  PubMed  Google Scholar 

  57. Wijnberg ID, Schrama SEA, Elgersma AE, Maree JTM, De Cocq P, Back W. Quantification of surface EMG signals to monitor the effect of a Botox treatment in six healthy ponies and two horses with stringhalt: preliminary study. Equine Vet J. 2009;41(3):313–8.

    Article  CAS  PubMed  Google Scholar 

  58. Draper ACE, Trumble TN, Firshman AM, Baird JD, Reed S, Mayhew IG, et al. Posture and movement characteristics of forward and backward walking in horses with shivering and acquired bilateral stringhalt. Equine Vet J. 2015;47(2):175–81.

    Article  CAS  PubMed  Google Scholar 

  59. Huntington PJ, Seneque Slocombe RF, Jeffcot LB, McLean A, Luff ARI. Use of phenytoin to treat horses with Australian stringhalt. Aust Vet J. 1991;68(7):221–4.

    Article  CAS  PubMed  Google Scholar 

  60. Torre F. Clinical diagnosis and results of surgical treatment of 13 cases of acquired bilateral stringhalt (1991–2003). Equine Vet J. 2005;37(2):181–3.

    Article  CAS  PubMed  Google Scholar 

  61. Adam-Castrillo D, White NA II, Donaldson LL, Furr MO. Effects of injection of botulinum toxin type B into the external anal sphincter on anal pressure of horses. Am J Vet Sci. 2005;65(1):26–30.

    Google Scholar 

  62. Galey FD. Botulism in the horse. Vet Clin N Am Equine Pract. 2001;17(3):579–88.

    Article  CAS  Google Scholar 

  63. Gutierrez-Nibeyro SD, Santos MP, White NA II, Brown JA, Adams MN, McKnight AL, et al. Effects of intrabursal administration of botulinum toxin type B on lameness in horses with degenerative injury to the podotrochlear apparatus. Equine Vet J. 2014;75(3):282–9.

    CAS  Google Scholar 

  64. Schoonover MJ, Jann HW, Blaik MA. Quantitative comparison of three commonly used treatments for navicular syndrome in horses. Am J Vet Res. 2005;66(7):1247–51.

    Article  PubMed  Google Scholar 

  65. Nibeyro SDG, White Na II, Wepy NM. Outcome of medical treatment for horses with foot pain: 56 cases. Equine Vet J. 2010;42(8):680–5.

    Article  Google Scholar 

  66. Bowker RM, Linder K, Sonea IM, Holland RE. Sensory innervation of the navicular bone and bursa in the foal. Equine Vet J. 1995;27(1):60–5.

    Article  CAS  PubMed  Google Scholar 

  67. DePuy T, Howard R, Keegan K, Wilson D, Kramer J, Cook JL, et al. Effects of intra-articular botulinum toxin type A in an equine model of acute synovitis: a pilot study. Am J Phys Med Rehabil. 2007;86(10):777–83.

    PubMed  Google Scholar 

  68. Peng L, Adler M, Demogines A, Borrell A, Liu H, Tao L, et al. Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins. PLoS Pathog. 2014;10(7):e1004177.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lahden eläinlääkäriasema, IVC Evidensia, Lahti, Finland

    Helka Heikkilä

Authors
  1. Helka Heikkilä
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helka Heikkilä .

Editor information

Editors and Affiliations

  1. Professor Emeritus of Neurology, Yale University School of Medicine, New Haven, CT, USA

    Bahman Jabbari

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Heikkilä, H. (2020). Botulinum Toxin Treatment in Veterinary Medicine: Clinical Implications. In: Jabbari, B. (eds) Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-50691-9_17

Download citation

Publish with us

Policies and ethics

Search

Navigation